Achelois Pharmaceuticals Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 2

Achelois Pharmaceuticals General Information

Description

Developer of non toxic therapeutics. The company develops non toxic therapeutics to inhibit tumors and eliminate pain caused by cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Primary Office
  • 953 Indiana Street
  • San Francisco, CA 94107
  • United States
+1 (650) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Achelois Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Startup
To view Achelois Pharmaceuticals’s complete valuation and funding history, request access »

Achelois Pharmaceuticals Executive Team (1)

Name Title Board Seat Contact Info
Chang-Zheng Chen Ph.D Founder
To view Achelois Pharmaceuticals’s complete executive team members history, request access »

Achelois Pharmaceuticals Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
California Institute for Quantitative Biosciences Accelerator/Incubator 000 0000 000000 0
JLABS Accelerator/Incubator Minority 000 0000 000000 0
To view Achelois Pharmaceuticals’s complete investors history, request access »